Product Images Contrave Extended-release

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Contrave Extended-release NDC 51267-890 by Nalpropion Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Table 1 - contrave er 01

Table 1 - contrave er 01

Naltrexone Hydrochloride Chemical Structure - contrave er 02

Naltrexone Hydrochloride Chemical Structure - contrave er 02

Bupropion Hydrochloride Chemical Structure - contrave er 03

Bupropion Hydrochloride Chemical Structure - contrave er 03

Figure 1 - contrave er 04

Figure 1 - contrave er 04

This appears to be a graph showing weight change from baseline over time (in weeks) for a group of participants taking a weight loss medication called CONTRAVE32/360 and a comparison group taking a placebo. The graph shows data up to 56 weeks and is divided into intervals of 4 weeks. However, the output is incomplete and some characters are missing, resulting in unclear information.*

Figure 1 - contrave er 05

Figure 1 - contrave er 05

The text seems to be a chart showing weight change from baseline over a period of 52 weeks. Two groups are being compared: a group taking Pacebo (probably placebo) and another group taking Contrave32360. The units for weight change are expressed as a percentage. Information about the size and characteristics of the groups is not available, and the meaning of the abbreviations ITT-LOCF and B3 is unclear.*

Figure 1 - contrave er 06

Figure 1 - contrave er 06

8 mg/90 mg 120-count Bottle Label - contrave er 07

8 mg/90 mg 120-count Bottle Label - contrave er 07

The text has information related to a medicine named "Contrave". It comes in a packaging of 120 extended-release tablets and contains 8mg of naloxone HCI and 90mg of bupropion HCI. Tablets should not be cut or crushed. The medicine is registered with the trademark of Nalpropion Pharmaceuticals LLC and distributed by Currax Pharmaceuticals LLC. Other details include the warning to not accept if the seal is broken or missing.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.